Jakob Magolan

Jakob Magolan is a Professor of Organic Chemistry at McMaster University in Hamilton, Canada, where he leads a research group specializing in organic synthesis and medicinal chemistry. His lab's work sits at the intersection of fundamental chemistry and real-world application, developing novel, efficient processes for the manufacture of pure bioactive compounds.  He is also the founder of Naturally Synthetic Inc., a university spin-off developing patented manufacturing technologies for pure cannabinoids. His research group discovered a breakthrough selective synthesis route for CBG, the result of a collaboration studying its antibiotic potential, that solved a longstanding chemistry problem and formed the basis of issued US patents and pending patents in Canada and Europe. A frequent industry speaker, Magolan is known for making cannabinoid chemistry accessible and actionable for product developers, investors, and researchers building the next generation of cannabis science and commerce. His work is driven by a conviction that the future of cannabinoid products, from consumer goods to FDA-approved medicines, will be built on reliable science, rigorous manufacturing standards, and a clear-eyed understanding of what pure molecules actually are.